Biosimilars and Steroid Management in Healthcare

This chapter explores the intricacies of biosimilars, including their equivalence to reference products and the challenges of switching medications. It highlights the impact of pharmacy benefit managers on drug pricing and the need for transparency in reimbursement systems. Additionally, the chapter delves into the prominent issues surrounding steroid use in rheumatoid arthritis, addressing the risks involved and the complexities of tapering treatment effectively.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app